Erythromycin ethosomal systems: Physicochemical characterization and enhanced antibacterial activity

Current Drug Delivery

Volumn 2, Issue 3, 2005, Pages 269-275

  Godin, Biana ^a   Touitou, Elka ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Antibiotics; Dermal infections; Erythromycin; Ethosomes; S. Aureus

Indexed keywords

ALCOHOL; DRUG CARRIER; ERYTHROMYCIN; HYDROETHANOL; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIAL SKIN DISEASE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG PENETRATION; DRUG SENSITIVITY; DRUG STABILITY; DRUG TRANSPORT; ETHOSOME; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LIGHT SCATTERING; MACROPHAGE MIGRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; ROOM TEMPERATURE; SKIN ABSCESS; SKIN FIBROBLAST; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRATUM CORNEUM; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; BACTERIAL INFECTIONS; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG DELIVERY SYSTEMS; ERYTHROMYCIN; MICE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

EID: 21744456048     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567201054367931     Document Type: Article

References (20)

1. Guay, D.R. 2003, 4, 1259-75.
2. Noble, W.C. Skin Br. J. Dermatol., 1998, 159, 9-12.
3. Tilles, S.A.; Slatore, C.G. Clin. Rev. Allergy Immunol. 2003, 24, 221-8.
4. Norlen, L. J. Invest. Dermatol. 2001, 117, 830-6.
5. Touitou, E.; Dayan, N.; Bergelson, L.; Godin, B.; Eliaz, M. J. Control Release 2000, 65, 403-18.
6. Godin, B.; Touitou, E. Crit. Rev. Ther. Drug Carrier Syst. 2003, 20, 63-102.
7. Lodzki, M.; Godin, B.; Rakou, L.; Mechoulam, R.; Gallily, R.; Touitou, E. J. Control Release 2003, 93, 377-87.
8. Dayan, N.; Touitou, E. Biomaterials 2000, 21, 1879-85.
9. Touitou, E. US patent 5,716,638, 1998.
10. Bernabeu, J.A.; Camacho, M.A.; Gil-Alegre, M.E.; Ruz, V.; Torres-Suarez, A.I. J. Pharm. Biomed. Anal. 1999, 21, 347-53.
11. Smoot, E.C.; Kucan, J.O.; Graham, D.R.; Barenfanger, J.E. J. Bum Care Rehabil. 1992, 13, 198-202.
12. Touitou, E.; Godin, B.; Dayan, N.; Weiss, C.; Piliponsky, A.; Levi-Schaffer, F. Biomaterials 2001, 22, 3053-9.
13. Godin, B.; Touitou, E. J. Control. Release. 2004, 94, 365-79.
14. Montenez, J.P.; Van Bambeke, F.; Piret, J.; Brasseur, R.; Tulkens, P.M.; Mingeot-Leclercq, M.P. Toxicol. Appl. Pharmacol. 1999, 156, 129-40.
15. Tyteca, D.; Schanck, A.; Dufrene, Y.F.; Deleu, M.; Courtoy, P.J.; Tulkens, P.M.; Mingeot-Leclercq, M.P. J. Membr. Biol. 2003, 192, 203-15.
16. Trima Israel Pharmaceutical Products Maabarot Ltd., data on SupraVir cream file.
17. Paolino, D.; Mardente, D.; Calcagno, MG.; Iannone, M.; Fresta, M. European Conference of Drug Delivery and Pharmaceutical Technology, Seville, Spain, 2004, O41.
18. Egbaria, K.; Weiner, N. Adv. Drug Deliv. Rev. 1990, 5, 287-93.
19. Touitou, E.; Levi-Schaffer, F.; Dayan, N.; Alhaique, F.; Riccieri, F. Int. J. Pharm. 1994, 103, 131-6.
20. Schmid, M.H.; Korting, H.C. 1996, 18, 335-42.